EyePoint Agrees to Pay $4.6 Million to Settle Kickback Allegations

EyePoint Pharmaceuticals (EYPT) has agreed to pay $4.6 million to settle allegations of paying kickbacks to healthcare providers in order to boost sales of its eyecare product, Dexycu.

By Dulan Lokuwithana, SA News Editor · Seeking Alpha · July 17, 2026, 15:13 UTC

EyePoint Agrees to Pay $4.6 Million to Settle Kickback Allegations

Tickers: $EYPT

Topics: kickback allegations pharmaceuticals regulation

Read the full article at Seeking Alpha

More World news

Oman Investment Authority Signs Multi-Billion Dollar Investment Package with Chinese Partners PR Newswire · November 12, 2026, 15:52 UTC
Nvidia Shares Drop 35% Following Resignation of CEO Jensen Huang Motley Fool · November 12, 2026, 15:49 UTC
Pomerantz Law Firm Investigates Potential Securities Fraud at ClearPoint Neuro (CLPT) PR Newswire · November 12, 2026, 15:50 UTC
Nvidia CEO Jensen Huang Resigns Amid Board Investigation The Verge · November 12, 2026, 15:48 UTC
GFL Environmental Shares Decline Following Preferred Share Conversion and Block Trade Seeking Alpha · November 12, 2026, 15:48 UTC
Medical Facilities Corp. Announces CAD 0.09 Per Share Quarterly Dividend Seeking Alpha · November 12, 2026, 15:45 UTC
Micron Shares Decline Following Resignation of Nvidia CEO Jensen Huang Motley Fool · November 12, 2026, 15:44 UTC
Wirex Launches Navoka AI Agent with Dedicated Bank Account and Card PR Newswire · November 12, 2026, 15:44 UTC
Mobility Global Shares Rise 12% Following Q3 Earnings Beat and Improved EBITDA Outlook Seeking Alpha · November 12, 2026, 15:44 UTC
Lucid Diagnostics Reports Q3 2026 Results Amid Transition to Medicare Reimbursement Motley Fool · November 12, 2026, 15:39 UTC